
SARS-CoV-2 – COVID-19 Vaccine Research Tools
-
AAV9 (SARS-CoV-2 Spike)COV-AV-SpAV-CMV-SCMV
-
AAV9 (SARS-CoV-2 Spike, S1 domain)COV-AV-S1pAV-CMV-S1CMV
-
Adenovirus (SARS-CoV-2 Nucleocapsid)COV-AD-NpAD-CMV-S-mCMV-copGFPCMV
-
Adenovirus (SARS-CoV-2 Spike)COV-AD-SpAD-CMV-N-mCMV-copGFPCMV
-
S-Pseudotyped IDLV lentivirus (GFP)COV-LENTI-GFPSpike protein of SARS-CoV-3eGFPYes
-
S-pseudotyped IDLV Lentivirus (Spike Protein)COV-LENTI-SSpike protein of SARS-CoV-2Spike RNA of SARS-CoV-2Yes
Covid-19 is caused by the coronavirus, SARS-CoV-2. The Spike protein (S), a structural protein on the surface of the CoV, mediates the interaction between the SARS-CoV-2 and Human cell via ACE2. Nucleocapsid (N) is a structural protein that holds the +RNA viral genome. Both the S protein and N proteins of SARS-CoV-2 are the leading target antigens in COVID-19 vaccine developments. Vigene provides S and N proteins in adenovirus, AAV and pseudotyped lentivirus that could be valuable for COVID-19 research and vaccine developments.